International Classification of Diseases for Oncology
Open accessThe DOI matches its Crossref record.
Abstract
Use of Immunofluorescence in the Diagnosis of Virus Infections.By P. S. Gardner.(Audio-tape slide programme; catalogue number 76-97; 34 slides and cassette; 33 minutes.Cost: can be obtained on loan (28 days for £216 including postage oneway and VAT.Programme can be purchased by bona fide medical personnel or organisations for £12 58 including postage and VAT)).Chelmsford: Medical Recording Service Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Items 101–161 of 161
Association of Soy and Fiber Consumption with the Risk of Endometrial Cancer
Goodman, M. T., Wilkens, L. R., Hankin, J. H., Lyu, L.-C., Wu, A. H., & Kolonel, L. N. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009270 · Cited by 329
Epidemiology of Hepatocellular Carcinoma
El-Serag, H. B. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70155-0 · Cited by 327
Ostrom, Q. T., Price, M., Ryan, K., Edelson, J., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac161 · Cited by 321
Epidemiology of hepatocellular carcinoma in USA
El‐Serag, H. B. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00168.x · Cited by 320
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
Paci, E., Puliti, D., Lopes Pegna, A., Carrozzi, L., Picozzi, G., Falaschi, F., Pistelli, F., Aquilini, F., Ocello, C., Zappa, M., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209825 · Cited by 311
Study, T. S. H. C., Franceschi, S., Lise, M., Clifford, G. M., Rickenbach, M., Levi, F., Maspoli, M., Bouchardy, C., Dehler, S., Jundt, G., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605756 · Cited by 307
Wyss, A., Hashibe, M., Chuang, S.-C., Lee, Y.-C. A., Zhang, Z.-F., Yu, G.-P., Winn, D. M., Wei, Q., Talamini, R., Szeszenia-Dabrowska, N., et al. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt029 · Cited by 307
Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012
Florio, A. A., Ferlay, J., Znaor, A., Ruggieri, D., Alvarez, C. S., Laversanne, M., Bray, F., McGlynn, K. A., & Petrick, J. L. (2020) · Cancer · doi:10.1002/cncr.32803 · Cited by 304
“In the first version of the ICD-O, Klatskin tumors did not have a unique morphology code.(16) The second version, ICD-O-2, was published in 1990 and assigned Klatskin tumors a unique morphology code (8162/3) but cross-referenced the morphology code to the topography code for intrahepatic bile duct cancer (C22.”
BackgroundJim, M. A., Pinheiro, P. S., Carreira, H., Espey, D. K., Wiggins, C. L., & Weir, H. K. (2017) · Cancer · doi:10.1002/cncr.30881 · Cited by 300
Mediterranean dietary pattern and cancer risk in the EPIC cohort
Couto, E., Boffetta, P., Lagiou, P., Ferrari, P., Buckland, G., Overvad, K., Dahm, C. C., Tjønneland, A., Olsen, A., Clavel-Chapelon, F., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.106 · Cited by 291
Cancer Statistics in Korea: Incidence, Mortality and Survival in 2006-2007
Jung, K.-W., Park, S., Kong, H.-J., Won, Y.-J., Boo, Y.-K., Shin, H.-R., Park, E.-C., & Lee, J.-S. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.8.1113 · Cited by 295
Glyphosate Use and Cancer Incidence in the Agricultural Health Study
Andreotti, G., Koutros, S., Hofmann, J. N., Sandler, D. P., Lubin, J. H., Lynch, C. F., Lerro, C. C., De Roos, A. J., Parks, C. G., Alavanja, M. C., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx233 · Cited by 292
Risk of Second Malignancies in Survivors of Retinoblastoma: More Than 40 Years of Follow-up
Marees, T., Moll, A. C., Imhof, S. M., de Boer, M. R., Ringens, P. J., & van Leeuwen, F. E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn394 · Cited by 286
International trends in incidence of cervical cancer: II. Squamous-cell carcinoma
Vizcaino, A. P., Moreno, V., Bosch, F. X., Mu�oz, N., Barros-Dios, X. M., Borras, J., & Parkin, D. M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000501)86:3<429::aid-ijc20>3.0.co;2-d · Cited by 285
Galateau-Salle, F., Churg, A., Roggli, V., & Travis, W. D. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.11.005 · Cited by 282
Jawad, M. U., Cheung, M. C., Min, E. S., Schneiderbauer, M. M., Koniaris, L. G., & Scully, S. P. (2009) · Cancer · doi:10.1002/cncr.24388 · Cited by 281
Hollingsworth, J. M., Miller, D. C., Daignault, S., & Hollenbeck, B. K. (2007) · Cancer · doi:10.1002/cncr.22600 · Cited by 275
Sant, M., Chirlaque Lopez, M. D., Agresti, R., Sánchez Pérez, M. J., Holleczek, B., Bielska-Lasota, M., Dimitrova, N., Innos, K., Katalinic, A., Langseth, H., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.022 · Cited by 274
The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women
Cote, M. L., Ruterbusch, J. J., Olson, S. H., Lu, K., & Ali-Fehmi, R. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0316 · Cited by 272
Adult glioma incidence trends in the United States, 1977–2000
Hess, K. R., Broglio, K. R., & Bondy, M. L. (2004) · Cancer · doi:10.1002/cncr.20621 · Cited by 270
Eltom, M. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1204 · Cited by 270
Trends in primary central nervous system lymphoma incidence and survival in the U.S.
Shiels, M. S., Pfeiffer, R. M., Besson, C., Clarke, C. A., Morton, L. M., Nogueira, L., Pawlish, K., Yanik, E. L., Suneja, G., & Engels, E. A. (2016) · British Journal of Haematology · doi:10.1111/bjh.14073 · Cited by 269
Cancer in 15- to 29-Year-Olds by Primary Site
Bleyer, A., Viny, A., & Barr, R. (2006) · The Oncologist · doi:10.1634/theoncologist.11-6-590 · Cited by 265
US lung cancer trends by histologic type
Lewis, D. R., Check, D. P., Caporaso, N. E., Travis, W. D., & Devesa, S. S. (2014) · Cancer · doi:10.1002/cncr.28749 · Cited by 264
Population‐based study of autoimmune conditions and the risk of specific lymphoid malignancies
Anderson, L. A., Gadalla, S., Morton, L. M., Landgren, O., Pfeiffer, R., Warren, J. L., Berndt, S. I., Ricker, W., Parsons, R., & Engels, E. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24287 · Cited by 263
Cancer treatment and survivorship statistics, 2025
Wagle, N. S., Nogueira, L., Devasia, T. P., Mariotto, A. B., Yabroff, K. R., Islami, F., Jemal, A., Alteri, R., Ganz, P. A., & Siegel, R. L. (2025) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.70011 · Cited by 261
The National Cancer Data Base report on colon cancer
Jessup, J. M., McGinnis, L. S., Steele, G. D., Menck, H. R., & Winchester, D. P. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960815)78:4<918::aid-cncr32>3.0.co;2-w · Cited by 260
Risk of Contralateral Testicular Cancer: A Population-based Study of 29 515 U.S. Men
Fosså, S. D., Chen, J., Schonfeld, S. J., McGlynn, K. A., McMaster, M. L., Gail, M. H., & Travis, L. B. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji185 · Cited by 251
Factors associated with survival in patients with meningioma
McCarthy, B. J., Davis, F. G., Freels, S., Surawicz, T. S., Damek, D. M., Grutsch, J., Menck, H. R., & Laws, E. R. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.88.5.0831 · Cited by 232
Adolescent and young adult oncology—past, present, and future
Close, A. G., Dreyzin, A., Miller, K. D., Seynnaeve, B. K. N., & Rapkin, L. B. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21585 · Cited by 225
Eloubeidi, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00228-4 · Cited by 222
Oral cavity cancer in developed and in developing countries: Population‐based incidence
de Camargo Cancela, M., Voti, L., Guerra‐Yi, M., Chapuis, F., Mazuir, M., & Curado, M. P. (2010) · Head & Neck · doi:10.1002/hed.21193 · Cited by 216
Disparities in liver cancer occurrence in the United States by race/ethnicity and state
Islami, F., Miller, K. D., Siegel, R. L., Fedewa, S. A., Ward, E. M., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21402 · Cited by 207
“1), respectively.(15,16) Ageadjusted rates per 100,000 were calculated using SEER*Stat software, version 8.”
MethodAn Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis
Adeloye, D., David, R. A., Aderemi, A. V., Iseolorunkanmi, A., Oyedokun, A., Iweala, E. E. J., Omoregbe, N., & Ayo, C. K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153496 · Cited by 200
Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010
Chokunonga, E., Borok, M. Z., Chirenje, Z. M., Nyakabau, A. M., & Parkin, D. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28063 · Cited by 196
“This study was undertaken as a project of the African Cancer Registry Network (AFRCN), which is supported financially by the Doris Duke Charitable Foundation (USA) and GlaxoSmithKline-Oncology.”
MethodInfluentialPinheiro, P. S., Sherman, R. L., Trapido, E. J., Fleming, L. E., Huang, Y., Gomez-Marin, O., & Lee, D. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0329 · Cited by 190
“Primary cancer site and histology data were coded according to the International Classification of Diseases for Oncology edition in use at the time of diagnosis, converted to the third edition, and categorized according to SEER (Surveillance Epidemiology End Results) site groups (10, 11).”
MethodMorton, L. M., Hartge, P., Holford, T. R., Holly, E. A., Chiu, B. C. H., Vineis, P., Stagnaro, E., Willett, E. V., Franceschi, S., La Vecchia, C., et al. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0693 · Cited by 187
Haselkorn, T., Whittemore, A. S., & Lilienfeld, D. E. (2005) · Cancer Causes & Control · doi:10.1007/s10552-005-3635-6 · Cited by 182
Sherman, M. E., Mink, P. J., Curtis, R., Cote, T. R., Brooks, S., Hartge, P., & Devesa, S. (2004) · Cancer · doi:10.1002/cncr.20080 · Cited by 179
Changing incidence of non‐Hodgkin lymphomas in the United States
Clarke, C. A., & Glaser, S. L. (2002) · Cancer · doi:10.1002/cncr.10403 · Cited by 173
“In the SEER data base, information for each diagnosis is abstracted from medical records(16) and includes demographic characteristics and tumor site and histology, as defined by the International Classification of DiseasesOncology, 2nd edition (ICD-O-2).(17) Eligible patients included all 83,251 persons diagnosed with…”
MethodBiliary tract cancer incidence and trends in the United States by demographic group, 1999‐2013
Van Dyke, A. L., Shiels, M. S., Jones, G. S., Pfeiffer, R. M., Petrick, J. L., Beebe‐Dimmer, J. L., & Koshiol, J. (2019) · Cancer · doi:10.1002/cncr.31942 · Cited by 170
Thyroid Cancer: Is the Incidence Still Increasing?
Hodgson, N. C., Button, J., & Solorzano, C. C. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.03.066 · Cited by 169
Olsen, J. H., Garwicz, S., Hertz, H., Jonmundsson, G., Langmark, F., Lanning, M., Lie, S. O., Moe, P. J., Møller, T., & Sankila, R. (1993) · BMJ · doi:10.1136/bmj.307.6911.1030 · Cited by 165
Miller, D. C., Hafez, K. S., Stewart, A., Montie, J. E., & Wei, J. T. (2003) · Cancer · doi:10.1002/cncr.11635 · Cited by 161
Body mass index and risk of ovarian cancer
Leitzmann, M. F., Koebnick, C., Danforth, K. N., Brinton, L. A., Moore, S. C., Hollenbeck, A. R., Schatzkin, A., & Lacey, J. V. (2009) · Cancer · doi:10.1002/cncr.24086 · Cited by 158
“Cancers were identified by anatomic site and histologic code using the International Classification of Disease for Oncology (ICD-O, second and third editions).(13) The endpoint considered was epithelial ovarian cancer (ICD-O C56.”
MethodCancer in schizophrenia: is the risk higher or lower?
Grinshpoon, A., Barchana, M., Ponizovsky, A., Lipshitz, I., Nahon, D., Tal, O., Weizman, A., & Levav, I. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.06.016 · Cited by 157
Joko‐Fru, W. Y., Jedy‐Agba, E., Korir, A., Ogunbiyi, O., Dzamalala, C. P., Chokunonga, E., Wabinga, H., Manraj, S., Finesse, A., Somdyala, N., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33014 · Cited by 143
Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review
de Geus, S. W. L., Eskander, M. F., Kasumova, G. G., Ng, S. C., Kent, T. S., Mancias, J. D., Callery, M. P., Mahadevan, A., & Tseng, J. F. (2017) · Cancer · doi:10.1002/cncr.30856 · Cited by 118
Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA
Schafer, E. J., Jemal, A., Wiese, D., Sung, H., Kratzer, T. B., Islami, F., Dahut, W. L., & Knudsen, K. E. (2023) · European Urology · doi:10.1016/j.eururo.2022.11.023 · Cited by 114
Shiels, M. S., Engels, E. A., Linet, M. S., Clarke, C. A., Li, J., Hall, H. I., Hartge, P., & Morton, L. M. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0040 · Cited by 112
Little, M. P., Rajaraman, P., Curtis, R. E., Devesa, S. S., Inskip, P. D., Check, D. P., & Linet, M. S. (2012) · BMJ · doi:10.1136/bmj.e1147 · Cited by 110
Dolecek, T. A., Dressler, E. V. M., Thakkar, J. P., Liu, M., Al‐Qaisi, A., & Villano, J. L. (2015) · Cancer · doi:10.1002/cncr.29379 · Cited by 104
Jamison, P. M., Noone, A.-M., Ries, L. A. G., Lee, N. C., & Edwards, B. K. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0996 · Cited by 101
HIV infection, immunosuppression, and age at diagnosis of non-AIDS-defining cancers
Shiels, M. S., Althoff, K. N., Pfeiffer, R. M., Achenbach, C. J., Abraham, A. G., Castilho, J., Cescon, A., D’Souza, G., Dubrow, R., Eron, J. J., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw764 · Cited by 95
Utada, M., Chernyavskiy, P., Lee, W. J., Franceschi, S., Sauvaget, C., Berrington de Gonzalez, A., & Withrow, D. R. (2019) · International Journal of Cancer · doi:10.1002/ijc.32014 · Cited by 68
Gaber, C., Meza, R., Ruterbusch, J. J., & Cote, M. L. (2017) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-016-0292-2 · Cited by 66
“Histological types were defined using the International Classification of Disease for Oncology, Third Edition (ICD-O3) [15].”
MethodChildhood Cancer Incidence Trends in Association With US Folic Acid Fortification (1986–2008)
Linabery, A. M., Johnson, K. J., & Ross, J. A. (2012) · Pediatrics · doi:10.1542/peds.2011-3418 · Cited by 51
Aschebrook-Kilfoy, B., Ward, M. H., Gierach, G. L., Schatzkin, A., Hollenbeck, A. R., Sinha, R., & Cross, A. J. (2012) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328347622f · Cited by 40
“Dietary variables were adjusted for energy intake using the nutrient density method (Willett, 1998), which expresses intake in units per 1000 calories.”
Method. FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients.
Park, L. S., Tate, J. P., Justice, A. C., Lo Re, V., Lim, J. K., Bräu, N., Brown, S. T., Butt, A. A., Gibert, C., Goetz, M. B., et al. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0582 · Cited by 38
Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004–2017
Withrow, D. R., Devesa, S. S., Deapen, D., Petkov, V., Van Dyke, A. L., Adamo, M., Armstrong, T. S., Gilbert, M. R., & Linet, M. S. (2021) · Cancer · doi:10.1002/cncr.33553 · Cited by 26
Long-term use of anti-cholesterol drugs and cancer risks in a Japanese population
Okita, Y., Sobue, T., Zha, L., Kitamura, T., Iwasaki, M., Inoue, M., Yamaji, T., Tsugane, S., & Sawada, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-53252-4 · Cited by 14
Metadata
- Authors
- Trott, P. A.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 1977-08
- Volume
- 30
- Issue
- 8
- Pages
- 782.3-782
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W1994863727
- Cited by
- 1,676
- References
- 0
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.